Mycobacterium tuberculosis– Specific CFP-10/ESAT-6 CD4 and CD8 T-Cell Non-IFN-γ+ Responses Are Common in Young Kenyan Children Despite Low Reported Tuberculosis Exposure
Open Access
- 21 January 2026
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (4) , e981-e989
Abstract
Background: Reduced early-life interferon-γ (IFN-γ) production capacity may limit sensitivity of IFN-γ release assays to detect Mycobacterium tuberculosis (Mtb)–specific responses in young children. Measuring non-IFN-γ cytokine responses may improve detection. Methods: Mononuclear cells isolated from peripheral blood from children exposed to HIV but uninfected and children unexposed to HIV in Western Kenya were collected at 6 to 10 weeks, and 12 and 24 months of age. Cells were incubated overnight with Mtb-specific CFP-10/ESAT-6 peptides and Staphylococcus enterotoxin B (positive control). CD4 and CD8 T-cell expression of IFN-γ and IL-2 and TNF cytokines was measured by flow cytometry. Results: Among 213 children, 28.6% had CFP-10/ESAT-6-specific CD4 and/or CD8 responses through 24 months. No children with Mtb-specific responses had a reported tuberculosis exposure. Mtb-specific non-IFN-γ+ responses (IL-2+ and/or TNF+) were more common than IFN-γ+ responses (26.3% vs 10.3%, P < .001). Non-IFN-γ cytokines alone identified 18.3% of children, compared with 2.4% identified by IFN-γ+ responses alone (P < .001). Prevalence of Mtb-specific responses was similar regardless of HIV exposure (HIV exposed, 31.5%; HIV unexposed, 25.5%, P = .33). At 6 to 10 weeks, children were more likely to have non-IFN-γ+ than IFN-γ+ responses to the positive control (96.3% vs 77.8%, P = .004); by 24 months, all children mounted both IFN-γ+ and non-IFN-γ+ responses. Conclusions: Mtb-specific CD4/CD8 responses were common among Kenyan children through 24 months, despite limited reported tuberculosis exposures. Non-IFN-γ+ cytokine expression identified substantially more children than IFN-γ+ alone, suggesting current IFN-γ release assays may miss early-life Mtb-specific responses.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases
- National Center for Advancing Translational Sciences
- National Institutes of Health (K23AI120793)
- National Institutes of Health (R01AI142647)
- National Institutes of Health (P30AI168386)
- National Institutes of Health (R21HD098746)
- National Institutes of Health (UL1TR000423)
This publication has 34 references indexed in Scilit:
- Association of Mycobacterium tuberculosis aerosolization and HIV coinfection in the index case with T cell responses in household contactsScientific Reports, 2025
- Specific CD4+ T cell phenotypes associate with bacterial control in people who ‘resist’ infection with Mycobacterium tuberculosisNature Immunology, 2024
- IFN-γ independent markers of Mycobacterium tuberculosis exposure among male South African gold minersEBioMedicine, 2023
- The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysisThe Lancet, 2020
- Paediatric tuberculosis transmission outside the household: challenging historical paradigms to inform future public health strategiesThe Lancet Respiratory Medicine, 2019
- IFN-γ-independent immune markers of Mycobacterium tuberculosis exposureNature Medicine, 2019
- Tuberculin skin test conversion and primary progressive tuberculosis disease in the first 5 years of life: a birth cohort study from Cape Town, South AfricaThe Lancet Child & Adolescent Health, 2018
- The global burden of tuberculosis mortality in children: a mathematical modelling studyThe Lancet Global Health, 2017
- Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort studyThe Lancet Respiratory Medicine, 2017
- Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trialThe Lancet, 2013